Mutation in the PTEN/MMAC1 gene in archival low grade and high grade gliomas

British Journal of Cancer

Volumn 79, Issue 9-10, 1999, Pages 1542-1548

  Davies, M P A ^a   Gibbs, F E M ^a   Halliwell, N ^a   Joyce, K A ^a   Roebuck, M M ^a   Rossi, M L ^b,c   Salisbury, J ^a   Sibson, D R ^a   Tacconi, L ^b   Walker, C ^a  

^a CLATTERBRIDGE HOSPITAL   (United Kingdom)

^b WALTON CENTRE FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^c UNIVERSITAT INTERNACIONAL DE CATALUNYA   (Spain)

Author keywords

Glioma; MMAC1; Mutation; Paraffin embedded tissue; PTEN

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; ASTROCYTOMA; CHILD; CHROMOSOME 10Q; CLINICAL ARTICLE; DNA SEQUENCE; FEMALE; GENE MUTATION; GENE SEQUENCE; GLIOBLASTOMA; GLIOMA; HUMAN; MALE; OLIGODENDROGLIOMA; PRIORITY JOURNAL; SCHOOL CHILD; SEQUENCE ANALYSIS; TUMOR SUPPRESSOR GENE;

EID: 0032976333     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690246     Document Type: Article

References (34)

1. Bigner SH, Mark J, Burger PC, Mahaley MS Jr, Bullard DE, Muhlbaier LH and Bigner DD (1988) Specific chromosomal abnormalities in malignant human gliomas. Cancer Res 48: 405-411
2. Black PM (1991) Brain tumours (first of two parts). N Engl J Med 324: 1471-1476
3. Boström J, Cobbers JMJL, Wolter M, Tabatabai G, Weber RG, Lichter P, Collins VP and Reifenberger G (1998) Mulation of the PTEN (MMAC1) tumor suppressor gene in a subset of glioblastomas but not in meningiomas with loss of chromosome arm 10q. Cancer Res 58: 29-33
4. Cairns P, Okami K, Halachmi S, Halachmi N, Esteller M, Herman JG, Jen J, Isaacs WB, Bova GS and Sidransky D (1997) Frequent inactivation of PTEN/MMAC1 in primary prostate cancer. Cancer Res 57: 4997-5000
5. Chiariello E, Roz L, Albarosa R, Magnani I and Finocchiaro G (1998) PTEN/MMAC1 mutations in primary glioblastomas and short-term cultures of malignant gliomas. Oncogene 16: 541-545
6. Going JJ and Lamb RF (1996) Practical histological microdissection for PCR analysis. J Pathol 179: 121-124
7. Guldberg P, Thor Straten P, Birck A, Ahrenkiel V, Kirkin AF and Zeuthen J (1997) Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma. Cancer Res 57: 3660-3663
8. Hildebrand J, Dewitte O, Dietrich PY and de Tribolet N (1997) Management of malignant brain tumors. Eur Neurol 38: 238-253
9. Karlbom AE, James CD, Boethius J, Cavenee WK, Collins VP, Nordenskjold M and Larsson C (1993) Loss of heterozygosity in malignant gliomas involves at least three distinct regions on chromosome 10. Hum Genet 92: 169-174
10. Kleihues P, Burger PC and Scheithauer B (1993) Histological Typing of Tumours of the Central Nervous System. Springer-Verlag: Berlin
11. Li DM and Sun H (1997) TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor β. Cancer Res 57: 2124-2129
12. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Pue J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittmann M, Tycko B, Hibshoosh H, Wigler MH and Parsons R (1997) PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast and prostate cancer. Science 275: 1943-1947
13. Liaw D, Marsh DJ, Li J, Dahia PLM, Wang SI, Zheng Z, Bose S, Call KM, Tsou HC, Peacocke M, Eng C and Parsons R (1997) Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet 16: 64-67
14. Liu W, James CD, Frederick L, Alderete BE and Jenkins RB (1997) PTEN/MMAC1 mutations and EGFR amplification in glioblastomas. Cancer Res 57: 5254-5257
15. Louis DN (1997) A molecular genetic model of astrocytoma histopathology. Brain Pathol 7: 755-764
16. Lynch ED, Ostermeyer EA, Lee MK, Arean JF, Ji HL, Dann J, Swisshelm K, Suchard D, MacLeod PM, Kvinnsland S, Tore Gjertsen B, Heimdal K, Lubs H, Møller P and King MC (1997) Inherited mutations in PTEN that are associated with breast cancer, Cowden disease and juvenile polyposis. Am J Hum Genet 61: 1254-1260
17. Marsh DJ, Dahia PLM, Zheng Z, Liaw D, Parsons R, Gorlin RJ and Eng C (1997) Germline mutations in PTEN are present in Bannayan-Zonana syndrome. Nat Genet 16: 333-334
18. Marsh DJ, Coulon V, Lunetta KL, Rocca-Serra P, Dahia PLM, Zheng Z, Liaw D, Caron S, Duboue B, Lin AY, Richardson AL, Bonnethlane JM, Bressieux JM, Cabarrot-Moreau A, Chompret A, Demange L, Eeles; RA, Yahanda AM, Fearon ER, Fricker JP, Gorlin RJ, Hodgson SV, Huson S, Lacombe D, LePrat F, Odent S, Toulouse C, Olopade OI, Sobol H, Tishler S, Woods CG, Robinson BG, Weber HC, Parsons R, Peacocke M, Longy M and Eng C (1998) Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation. Hum Mol Genet 7: 507-515
19. Myers MP and Tonks NK (1997) PTEN: sometimes taking it off can be better than putting it on. Am J Hum Genet 61: 1234-1238
20. Nelen MR, van Staveren WCG, Peeters EAJ, Ben Hassel M, Gorlin RJ, Hamm H, Lindboe CF, Fryns JP, Sijmons RH, Woods DG, Mariman ECM, Padberg GW and Kremer H (1997) Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease. Hum Mol Genet 6: 1383-1387
21. Nollau P and Wagener C (1997) Methods for detection of point mutations: performance and quality assessment. Clin Chem 43: 1114-1128
22. Ohgaki H, Schäuble B, zur Hausen A, von Ammon K and Kleihues P (1995) Genetic alterations associated with the evolution and progression of astrocytic brain tumours. Virchows Arch 427: 113-118
23. Parsons R (1998) Phosphatases and tumorigenesis. Curr Opin Oncol 10: 88-91
24. Rasheed BK, McLendon RE, Friedman HS, Friedman AH, Fuchs HE, Bigner DD and Bigner SH (1995) Chromosome 10 deletion mapping in human gliomas: a common deletion region in 10q25. Oncogene 10: 2243-2246
25. Rasheed BKA, Stenzel TT, McLendon RE, Parsons R, Friedman AH, Friedman HS, Bigner DD and Bigner SH (1997) PTEN gene mutations are seen in high-grade but not in low-grade gliomas. Cancer Res 57: 4187-4190
26. Rhei E, Kang L, Bogomolniy F, Federici MG, Borgen PI and Boyd J (1997) Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas. Cancer Res 57: 3657-3659
27. Risinger JI, Hayes K, Berchuck A and Barrett JC (1997) PTEN/MMAC1 mutations in endometrial cancers. Cancer Res 57: 4736-4738
28. Sakurada A, Suzuki A, Sato M, Yamakawa H, Orikasa K, Uyeno S, Ono T, Ohuchi N, Fujimura S and Horii A (1997) Infrequent genetic alterations of the PTEN/MMAC1 gene in Japanese patients with primary cancers of the breast, lung, pancreas, kidney and ovary. Jpn J Cancer Res 88: 1025-1028
29. Sonoda Y, Murakami Y, Tominaga T, Kayama T, Yoshimoto T and Sekiya T (1996) Deletion mapping of chromosome 10 in human glioma. Jpn J Cancer Res 87: 363-367
30. Steck PA, Ligon AH, Cheong P, Yung WK and Pershouse MA (1995) Two tumor suppressive loci on chromosome 10 involved in human glioblastomas. Genes Chromosomes Cancer 12: 255-261
31. Steck PA, Pershouse MA, lasser SA, Yung WKA, Lin H, Ligon AH, Langford LA, Baumgard ML, Hattier T, Davis T, Frye C, Hu R, Swedlund B, Teng DHF and Tavtigian SV (1997) Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 15: 356-362
32. Suzuki H, Freije D, Nusskern DR, Okami K, Cairns P, Sidransky D, Isaacs WB and Bova GS (1998) Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues. Cancer Res 58: 204-209
33. Tashiro H, Blazes MS, Wu R, Cho KR, Bose S, Wang SI, Li J, Parsons R and Ellenson LH (1997) Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies. Cancer Res 57: 3935-3940
34. Wang SI, Puc J, Li J, Bruce JN, Cairns P, Sidransky and Parsons R (1997) Somatic mutations of PTEN in glioblastoma multiforme. Cancer Res 57: 4183-4186